Clinical trials routinely exclude expectant mothers. This is unethical and unscientific, and regulators must mandate change, says Françoise Baylis, in the second of three related pieces on gender bias in biomedicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A Learning Healthcare System for pregnant and breastfeeding women: what do women during preconception, pregnancy, and nursing think? – A qualitative study
BMC Pregnancy and Childbirth Open Access 18 April 2022
-
A qualitative study on stakeholders’ views on the participation of pregnant women in the APOSTEL VI study: a low-risk obstetrical RCT
BMC Pregnancy and Childbirth Open Access 11 February 2019
-
The Healthy Pregnancy Research Program: transforming pregnancy research through a ResearchKit app
npj Digital Medicine Open Access 05 September 2018
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects; available at http://www.cioms.ch/frame_guidelines_nov_2002.htm
Baylis, F. & Kaposy, C. J. Obstet. Gynaecol. Can. 32, 473–476 (2010).
Lyerly, A. D., Little, M. O. & Faden, R. Int. J. Fem. Approaches Bioeth. 1, 5–22 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baylis, F. Pregnant women deserve better. Nature 465, 689–690 (2010). https://doi.org/10.1038/465689a
Published:
Issue Date:
DOI: https://doi.org/10.1038/465689a
This article is cited by
-
A Learning Healthcare System for pregnant and breastfeeding women: what do women during preconception, pregnancy, and nursing think? – A qualitative study
BMC Pregnancy and Childbirth (2022)
-
A qualitative study on stakeholders’ views on the participation of pregnant women in the APOSTEL VI study: a low-risk obstetrical RCT
BMC Pregnancy and Childbirth (2019)
-
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
Drug Safety (2019)
-
Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach
Trials (2018)
-
Towards an appropriate framework to facilitate responsible inclusion of pregnant women in drug development programs
Trials (2018)